Phentermine Hydrochloride Capsules Recalled Due to Manufacturing Quality Deviations
KVK Tech, Inc. is recalling Phentermine Hydrochloride Capsules 30mg due to manufacturing quality deviations. The recall affects approximately 9,680 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II voluntary recall with no reported illnesses or injuries. The hazard is identified as a manufacturing quality deviation without specification of a particular safety concern or adverse event, consistent with a voluntary precautionary recall.
Plain-English summary
KVK Tech, Inc. is recalling Phentermine Hydrochloride Capsules, USP 30mg (100-count bottles) due to manufacturing quality deviations. The affected products are identified by lot numbers 18350A and 18351A, with an expiration date of June 30, 2027.
The recall was initiated by the manufacturer on May 9, 2025, and affects approximately 9,680 bottles distributed nationwide. This is a voluntary, firm-initiated recall classified as FDA Class II.
Patients currently taking the affected medication should consult their healthcare provider or pharmacist. Do not stop taking your medication without medical guidance. Contact your pharmacy or healthcare provider for information on obtaining a replacement or alternative medication.
The recalled product
- Product
- PHENTERMINE HYDROCHLORIDE (PHENTERMINE HYDROCHLORIDE)
- Brand
- PHENTERMINE HYDROCHLORIDE
- Manufacturer
- KVK Tech, Inc.
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot#: 18350A
- 18351A
- Exp 6/30/2027
UPCs (3)
- 0310702027107
- 0310702028104
- 0310702026100
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27